Title: Discovery and structure-activity relationship of potent and selective covalent inhibitors of transglutaminase 2 for Huntington's disease.
Journal: Journal of medicinal chemistry 20120209
119430-40-9
13997-69-8
621-38-5
1156153-35-3
1567043-72-4
1154729-31-3
1334147-02-2 | [2-(4-methyl-1,3-thiazol-2-yl)ethyl]urea | AA01AJOF | MFCD18263568
59939-07-0 | 3-cyclopropylcyclohexan-1-one | AA01AJU2 | MFCD19686436
79314-52-6 | 2-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride | AA01AJXL | MFCD19982393
1206776-00-2 | N-(4-aminocyclohexyl)methanesulfonamide hydrochloride | AA01AK5K | MFCD20233459
6063-50-9 | 7-(((Cyclohexylmethyl)amino)methyl)-5-(methoxymethyl)quinolin-8-ol | AA01AKB6 | MFCD01124802
1182757-92-1 | 2-[(3-bromophenyl)methyl]-4-methoxybutanoic acid | AA01AKFC | MFCD12152859
83253-34-3 | 6-methylimidazo[2,1-b][1,3]thiazole-5-carbonitrile | AA01AKMK | MFCD12403317
1354949-89-5 | 5-amino-4,4-dimethylpentan-2-ol hydrochloride | AA01AKQU | MFCD20233586
858208-68-1 | 3-(methylsulfanyl)-2-phenylpropanoic acid | AA01AKVY | MFCD17288065
491-02-1 | (1R,2R,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol | AA01AL0Q | MFCD01941448